INSIG indapamide hemihydrate 2.5mg sugar coated tablet blister pack Australia - Inggris - Department of Health (Therapeutic Goods Administration)

insig indapamide hemihydrate 2.5mg sugar coated tablet blister pack

arrotex pharmaceuticals pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, sugar coated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; shellac; white beeswax; carnauba wax - management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.

Proflavine 0.1% cream Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

proflavine 0.1% cream

a a h pharmaceuticals ltd - proflavine hemisulfate - cutaneous cream - 1mg/1gram

Proflavine 0.1% cream Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

proflavine 0.1% cream

j m loveridge ltd - proflavine hemisulfate - cutaneous cream - 1mg/1gram

Proflavine 0.1% cream Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

proflavine 0.1% cream

alliance healthcare (distribution) ltd - proflavine hemisulfate - cutaneous cream - 1mg/1gram

Proflavine Hemisulfate Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

proflavine hemisulfate

virbac (australia) pty ltd - proflavine hemisulfate - unknown - proflavine hemisulfate anilide/aniline active 0.0 - active constituent

Riboflavin 5' Phosphate Sodium Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

riboflavin 5' phosphate sodium

ceva animal health pty ltd - riboflavin-5-phosphate sodium - unknown - riboflavin-5-phosphate sodium vitamin-b2 active 0.0 - active constituent

Acriflavine Emulsion Namibia - Inggris - Namibia Medicines Regulatory Council

acriflavine emulsion

resmed pharmaceuticals - acriflavine bpc - emulsion - acriflavine bpc 0.10g/100ml

Halaven Uni Eropa - Inggris - EMA (European Medicines Agency)

halaven

eisai gmbh - eribulin - breast neoplasms; liposarcoma - antineoplastic agents - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimens for advanced disease (see section 5.1). prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease (see section 5.1).

Acriflavine Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

acriflavine

psm healthcare ltd trading as api consumer brands - acriflavine 0.1%{relative} - topical solution - 0.1% w/v - active: acriflavine 0.1%{relative}

VITAMIN B COMPLEX- thiamine hydrochloride, riboflavin 5 phosphate sodium, pyridoxine hydrochloride, dexpanthenol and niacinamide Amerika Serikat - Inggris - NLM (National Library of Medicine)

vitamin b complex- thiamine hydrochloride, riboflavin 5 phosphate sodium, pyridoxine hydrochloride, dexpanthenol and niacinamide

raw materials international overseas llc - riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - riboflavin 2 mg in 1 ml - in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. sensitivity to the ingredients listed.